Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 42,786 | 33,126 | 33,747 | 36,009 | 37,579 |
| Cost of Goods | 1,465 | 1,911 | 1,486 | 911 | 1,194 |
| Gross Profit | 41,321 | 31,215 | 32,261 | 35,098 | 36,385 |
| Operating Expenses | 69,906 | 65,885 | 70,555 | 67,269 | 66,152 |
| Operating Income | -28,120 | -33,759 | -37,808 | -31,260 | -29,573 |
| Interest Expense | 8,949 | 5,884 | 6,208 | 6,073 | 5,784 |
| Other Income | 60,928 | 2,352 | 2,309 | 2,839 | 2,854 |
| Pre-tax Income | 23,859 | -37,291 | -41,707 | -34,494 | -32,503 |
| Income Tax | 67 | 71 | 130 | 12 | 127 |
| Net Income Continuous | 23,792 | -37,362 | -41,837 | -34,506 | -32,630 |
| Net Income | $23,792 | $-37,362 | $-41,837 | $-34,506 | $-32,630 |
| EPS Basic Total Ops | 2.26 | -4.85 | -5.40 | -4.50 | -4.35 |
| EPS Basic Continuous Ops | 2.95 | -4.85 | -5.47 | -4.52 | -4.28 |
| EPS Diluted Total Ops | -2.97 | -4.85 | -5.40 | -4.50 | -4.35 |
| EPS Diluted Continuous Ops | 2.31 | -4.85 | -5.47 | -4.52 | -4.28 |
| EPS Diluted Before Non-Recurring Items | -3.00 | -4.80 | -5.40 | N/A | N/A |
| EBITDA(a) | $-27,302 | $-34,377 | $-38,535 | $-31,911 | $-30,314 |